The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutations.

Saved in:
Bibliographic Details
Title: The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutations.
Authors: Patil T; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA. Electronic address: https://twitter.com/TejasPatilMD., Gao D; Department of Biostatistics, University of Colorado School of Medicine, Aurora, CO, USA., Watson A; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA., Sakamoto M; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA., Nie Y; Yale Cancer Center, Yale University, New Haven, CT, USA., Gibson A; Glans-Look Lung Cancer Research, Cumming School of Medicine, University of Calgary, Alberta, Canada., Dean ML; Glans-Look Lung Cancer Research, Cumming School of Medicine, University of Calgary, Alberta, Canada., Yoder BA; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA., Miller E; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA., Stalker M; Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA, USA., Aisner DL; Department of Pathology, University of Colorado School of Medicine, Aurora, CO, USA., Bunn PA; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA., Schenk EL; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA., Marmarelis ME; Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA, USA., Bennati C; Department of Hematology and Oncology, AUSL della Romagna, Ravenna, Italy., Navani V; Glans-Look Lung Cancer Research, Cumming School of Medicine, University of Calgary, Alberta, Canada., Zhang Y; Hunan Cancer Hospital, Xiangya School of Medicine, Changsha, China., Camidge DR; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA.
Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2025 Jan; Vol. 199, pp. 108040. Date of Electronic Publication: 2024 Nov 25.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1872-8332
DOI:10.1016/j.lungcan.2024.108040